Progesterone
- Generic Name
- Progesterone
- Brand Names
- Bijuva, Crinone, Endometrin, Prochieve, Prometrium
- Drug Type
- Small Molecule
- Chemical Formula
- C21H30O2
- CAS Number
- 57-83-0
- Unique Ingredient Identifier
- 4G7DS2Q64Y
- Background
Progesterone is a hormone that occurs naturally in females, and is essential for endometrial receptivity, embryo implantation, and the successful establishment of pregnancy. A low progesterone concentration or an insufficient response to progesterone can cause infertility and pregnancy loss . Progesterone is used in various contraceptive preparations to prev...
- Indication
Gelatinized capsules
The gelatinized capsules are indicated for use in the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea .
Vaginal gel
...
- Associated Conditions
- Abnormal Uterine Bleeding, Amenorrhea, Endometrial hyperplasia caused by conjugated estrogen, Moderate to Severe Vasomotor Symptoms, Pregnancy, Secondary Amenorrhea, Recurrent spontaneous preterm birth
- Associated Therapies
- Assisted Reproductive Technology therapy
Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert
- First Posted Date
- 2024-11-01
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Daré Bioscience, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06668896
Effect of Progesterone Administration on Severely Head Injured Patients
- Conditions
- Interventions
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 50
- Registration Number
- NCT06631547
Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression
- Conditions
- Interventions
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2024-09-24
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 75
- Registration Number
- NCT06610305
- Locations
- 🇺🇸
University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States
To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 176
- Registration Number
- NCT06091436
- Locations
- 🇨🇳
The Sixth Affiliated Hospital, Sun Yat-sen University Guangdong Gastrointestinal Hospital, Guangzhou, Guangdong, China
Adjunctive Vaginal Progesterone in Management of Preterm Labor
- First Posted Date
- 2023-08-18
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- Chulalongkorn University
- Target Recruit Count
- 48
- Registration Number
- NCT05997563
- Locations
- 🇹🇭
Vorapong Phupong, Bangkok, Thailand
Rhythmic Estradiol and Bone Health
- Conditions
- Interventions
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2024-07-19
- Target Recruit Count
- 48
- Registration Number
- NCT05903820
- Locations
- 🇳🇱
Amsterdam UMC, Amsterdam, Netherlands
Estrogen Supplementation and Bone Health in Women With CF
- Conditions
- Interventions
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 75
- Registration Number
- NCT05704036
- Locations
- 🇺🇸
Johns Hopkins, Baltimore, Maryland, United States
GnRH Agonist for Luteal Phase Support.
- Conditions
- Interventions
- First Posted Date
- 2022-08-02
- Last Posted Date
- 2022-08-02
- Lead Sponsor
- Shaare Zedek Medical Center
- Target Recruit Count
- 150
- Registration Number
- NCT05484193
- Locations
- 🇮🇱
Shaare Zedek medical Center, Jerusalem, Israel
Addition of Gonadotropin Releasing Hormone Agonist to Luteal Phase Support
- Conditions
- Interventions
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Alexandria University
- Target Recruit Count
- 75
- Registration Number
- NCT05286554
- Locations
- 🇪🇬
Alexandria University, Alexandria, Egypt
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- Conditions
- Interventions
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2024-01-25
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 103
- Registration Number
- NCT05282277
- Locations
- 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.